Evidence map›Paper›PMID 32187647›Full record

ArticleImmunology2020

A role for cell-autocrine interleukin-2 in regulatory T-cell homeostasis.

Amanpreet Singh Chawla, Jasneet Kaur Khalsa, Atika Dhar, Suman Gupta, Danish Umar, Gopalakrishnan Aneeshkumar Arimbasseri, Vineeta Bal, Anna George, Satyajit Rath

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Application of adoptive cell therapy in malignant melanoma.Journal of translational medicine · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Automated clustering reveals CD4Frontiers in immunology · 2023
    Article
  8. Cell Therapy with Human Reprogrammed CD8International journal of molecular sciences · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Amanpreet Singh ChawlaNational Institute of Immunology, New Delhi, India.
Jasneet Kaur KhalsaNational Institute of Immunology, New Delhi, India.
Atika DharNational Institute of Immunology, New Delhi, India.
Suman GuptaNational Institute of Immunology, New Delhi, India.
Danish UmarNational Institute of Immunology, New Delhi, India.
Gopalakrishnan Aneeshkumar ArimbasseriNational Institute of Immunology, New Delhi, India.
Vineeta BalNational Institute of Immunology, New Delhi, India.
Anna GeorgeNational Institute of Immunology, New Delhi, India.ORCID 0000-0001-9401-0944
Satyajit RathNational Institute of Immunology, New Delhi, India.ORCID 0000-0002-7343-1173
National Institute of Immunology · IN

Funding

Department of Biotechnology , Ministry of Science and Technology BT/PR12849/MED/15/35/2009Department of Biotechnology , Ministry of Science and Technology BT/PR14420/Med/29/213/2010Department of Biotechnology , Ministry of Science and Technology BT/PR-14592/BRB/10/858/2010Department of Science and Technology, Ministry of Science and Technology EMR/2015/001074Department of Science and Technology, Ministry of Science and Technology SB/SO/HS/210/2013Department of Science and Technology, Ministry of Science and Technology SR/SO/HS-0005/2011
6 · The paper itself

Abstract

Activated T-cells make both interleukin-2 (IL2) and its high-affinity receptor component CD25. Regulatory CD4 T-cells (Treg cells) do not make IL2, and the IL2-CD25 circuit is considered a paracrine circuit crucial in their generation and maintenance. Yet, all T-cells are capable of making IL2 at some stage during differentiation, making a cell-intrinsic autocrine circuit additionally possible. When we re-visited experiments with mixed bone marrow chimeras using a wide range of ratios of wild-type (WT) and IL2-/- genotype progenitors, we found that, as expected, thymic Treg cells were almost equivalent between WT and IL2-/- genotypes at ratios with WT prominence. However, at WT-limiting ratios, the IL2-/- genotype showed lower thymic Treg frequencies, indicating a role for cell-intrinsic autocrine IL2 in thymic Treg generation under IL2-limiting conditions. Further, peripheral IL2-/- naive CD4 T-cells showed poor conversion to inducible Tregs (pTregs) both in vivo and in vitro, again indicating a significant role for cell-intrinsic autocrine IL2 in their generation. Peripherally, the IL2-/- genotype was less prominent at all WT:IL2-/- ratios among both thymic Tregs (tTregs) and pTregs, adoptively transferred IL2-/- Tregs showed poorer survival than WT Tregs did, and RNA-seq analysis of WT and IL2-/- Tregs showed interesting differences in the T-cell receptor and transforming growth factor-beta-bone morphogenetic protein-JNK pathways between them, suggesting a non-titrating role for cell-intrinsic autocrine IL2 in Treg programming. These data indicate that cell-intrinsic autocrine IL2 plays significant roles in Treg generation and maintenance.

Indexed as

AnimalsAutocrine CommunicationBone Morphogenetic ProteinsCell DifferentiationCell ProliferationCells, CulturedHomeostasisInterleukin-2Lymphocyte ActivationMAP Kinase Kinase 4MiceMice, Inbred C57BLMice, KnockoutSignal TransductionT-Lymphocytes, RegulatoryTransforming Growth Factor betaBone Morphogenetic ProteinsInterleukin-2MAP Kinase Kinase 4Transforming Growth Factor betaautocrineFOXP3IL2paracrineTregs

Identifiers

PMID32187647
PMCPMC7341549
OpenAlexW3012516372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.